BIDMC Research Investigator / Faculty Information

Leo E Otterbein PhD

Associate Professor

Surgery

Faculty Appointment:

Surgery

   

Contact Information:

 
Title:   Staff PhD
Office:   RN-370G
Phone:   617-735-2851
Fax:   617-735-2844
Email:   lotterbe@bidmc.harvard.edu
Address:   Beth Israel Deaconess Medical Center
 330 Brookline Ave; RN-370G
 Boston, MA 02215

Advanced Degree And Training Info:

Year

Institution

Area or Rank

2000  Johns Hopkins University  Physiology
2000  Yale University  Research Associate
2001  University of Pittsburgh Sch of Med  Assistant Professor

Research Team Listing

Beek Chin PhD

Eva Csizmadia MSc David Gallo BS Kaori Kuramitsu MD

Theresa MacDonald BS

Kyoichiro Maeshima MD,PhD Steven Tizio Barbara Wegiel PhD

Areas of Interest:

Immunology, Transplantation

Infectious Diseases, Inflammation Vascular Biology  

Major Research Theme:

My research focuses around the oxidative stress response. My interest is in studying the effects of carbon monoxide and its ability to provide a cytoprotective response both in vitro and in vivo. Carbon monoxide at low concentrations has been shown by my myself and others to exert potent anti-inflammatory, anti-proliferative and anti-apoptotic effects. In models of endotoxic shock, acute hepatitis, organ transplantation, ischemia/reperfusion injury, and arteriosclerosis among others, CO has been shown to reestablish homeostasis and provide potent protection.  My research also examines the role of the inducible enzyme heme oxygenase-1 (HO-1), an enzyme present in all cells that produces CO endogenously. HO-1 has been characterized as a protective gene in that if induced prior to an insult exerts potent protective effects.  We hypothesized that CO, one of three products of heme catalysis by HO-1, was a potential mechanism. My current area of focus include investigations examining the mechanism by which CO functions to exert such potent anti-inflammatory effects. To date, there are a number of gene targets including the nitric oxide synthases, mitochondrial oxidases as well as signaling molecules that are being explored including the MAP kinases, PPARg, and HIF1-a. We have shown that CO differentially regulates these gene products depending on the model, the cell type and organ system involved. Increasing our understanding of how CO functions to exert its effects will lead potentially to a novel therapeutic modality and translate into a treatment for a variety of disorders including vascular injury ischemia/reperfusion injury and organ transplantation.

Select Major Publications:    List of Publications via PubMed database at NIH NLM

Chin, B.Y., Jiang, G., Wegiel, B., Wang, H., MacDonald, T., Zhang, X., Cszimadia, E., Bach, F.H., Lee, P.J., Otterbein, L.E. HIF1a Stabilization by Carbon Monoxide Results in Cytoprotective Preconditioning. Proc. Natl. Acad. Sci.USA. 2007. 104:5109-14.
Otterbein LE, Zuckerbraun BS, Bach FH, Billiar TR, Choi AM, Soares MP.  Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and balloon injury.  Nature Medicine 2003;2:183-190.
Otterbein LE, Bach FH, Alam J, Soares MP, Lu HT, Wysk M, Davis RJ, Flavell RA, Choi AMK.  Carbon monoxide mediates anti-inflammatory effects via the mitogen-activated protein kinase pathway.  Nature Medicine 2000;6:422-428.
Bilban M, Bach FH, Otterbein SL, Ifedigbo E, de Costa d'Avila J, Esterbauer H, Chin BY, Usheva A, Robson SC, Wagner O, Otterbein LE. Carbon monoxide orchestrates a protective response through PPARgamma. Immunity 2006; 24:601-10
Zuckerbraun, BS, Chin, BY, Wegiel, B, Billiar, TR, Csizmadia, E, Rao, J, Shimoda, L, Kano, S, Otterbein, LE. Carbon monoxide reverses established pulmonary hypertension. J. Exp. Med.  2006; 203: 2109-19.

External Recognition:

2004-present - Member, NIH Study Section; Physician/Scientist KO8 Grants Review
2006 (summer) - visiting professor, Carderelli Hospital, Center for Biotechnology
2002-2004 Grant Reviewer, Vienna National Funding Agency
2003-2004      Member Mid-Atlantic Affiliate American Heart Association Grant Review Panel
2004            Member, NIH Special Emphasis RFA Review Panel for Progression of
            Cardiovascular Disease in Type I Diabetes
2004-2008  American Heart Association - Northeast Affiliate Grant Review Panel
2005            Member Scientific Advisory Board for iNO Therapeutics
2005-2009 Member New England Affiliate American Heart Association Grant Review Panel
2005-2009      Member NIH Study Section; Physican/Scientist KO8 Grants Review

1996            President’s Award for outstanding contribution to the company.  Scios, Inc.
2000            Travel Award for best student abstract.  American Thoracic Society
2003            Senior Vice Chancellor’s Research Seminar Award for extraordinary contribution to the Medical School.  University of Pittsburgh    
                  School of Medicine; Pittsburgh, PA  

Major Collaborative Activities:

MIT department of Chemical Engineering (Clark Colton) - effects of carbon monoxide on oxygen consumption
Brigham and Womens Hospital (Mark Perrella) - joint interest in heme oxygenase (cardiopulmonary)
Childrens Hospital (Stella Kourembanas) - joint interest in heme oxygenase (cardiopulmonary)
BIDMC - (Frank Selke) - effects of CO in vascular biology

Investigator's Web Site:

        

Harvard Catalyst Site:

   
 

Copyright 2009 Beth Israel Deaconess Medical Center | Contact Research Webmaster

IP Address: 38.107.191.87   |  Web Server: research.bidmc.harvard.edu   |  Database Server: Colorado\SQL17   |  App Path: /research/ResearchPIInfo.ASP   |  Version:

Browser: CCBot/1.0 (+http://www.commoncrawl.org/bot.html)
SecurityGroup: